Viral Vector Production (Research-use) Market Size, Share & Trends Report

Viral Vector Production (Research-use) Market Size, Share & Trends Analysis Report By Vector Type (Adeno-Associated Virus, Lentivirus), By Application, By Workflow, By End-use, By Region, And Segment Forecasts, 2024 - 2030

Report ID: GVR-4-68039-359-7
Number of Report Pages: 100
Format: PDF, Horizon Databook

Historical Range: 2018 - 2022
Forecast Period: 2024 - 2030
Industry: Healthcare

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Viral Vector Production (Research-use) Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Viral Vector Production (Research-Use) Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining Power of the Suppliers
3.4.1.2. Bargaining Power of the Buyers
3.4.1.3. Threats of Substitution
3.4.1.4. Threats From New Entrants
3.4.1.5. Competitive Rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political Landscape
3.4.2.2. Economic and Social Landscape
3.4.2.3. Technological Landscape
3.4.2.4. Environmental Landscape
3.4.2.5. Legal Landscape
Chapter 4. Viral Vector Production (Research-use) Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Viral Vector Production (Research-use) Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Vector Type
4.3.1. Vector Type Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Adeno-associated Virus (AAV)
4.4.1. Adeno-associated Virus (AAV) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Lentivirus
4.5.1. Lentivirus Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Adenovirus
4.6.1. Adenovirus Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Retrovirus
4.7.1. Retrovirus Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Others
4.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Viral Vector Production (Research-use) Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Viral Vector Production (Research-use) Application Movement Analysis, 2023 & 2030 (USD Million)
5.3. Cell & Gene Therapy Development
5.3.1. Cell & Gene Therapy Development Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Vaccine Development
5.4.1. Vaccine Development Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Biopharmaceutical & Pharmaceutical Discovery
5.5.1. Biopharmaceutical & Pharmaceutical Discovery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Biomedical Research
5.6.1. Biopharmaceutical & Pharmaceutical Discovery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Viral Vector Production (Research-use) Market: Workflow Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Viral Vector Production (Research-use) Workflow Movement Analysis, 2023 & 2030 (USD Million)
6.3. Upstream Processing
6.3.1. Vector Amplification & Expansion Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. Vector Recovery/Harvesting
6.3.3. Vector Recovery/Harvesting Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Downstream Processing
6.4.1. Downstream Processing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Purification
6.5.1. Purification Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Fill-finish
6.6.1. Fill-finish Vector Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Viral Vector Production (Research-use) Market: Regional Estimates & Trend Analysis
7.1. Viral Vector Production (Research-use) Market Share, By Region, 2023 & 2030 (USD Million)
7.2. North America
7.2.1. North America Viral Vector Production (Research-use) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Viral Vector Production (Research-use) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Canada Viral Vector Production (Research-use) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4. Mexico
7.2.4.1. Mexico Viral Vector Production (Research-use) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Viral Vector Production (Research-use) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. UK Viral Vector Production (Research-use) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Germany Viral Vector Production (Research-use) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. France Viral Vector Production (Research-use) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Italy Viral Vector Production (Research-use) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Spain Viral Vector Production (Research-use) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Viral Vector Production (Research-use) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. China
7.4.2.1. China Viral Vector Production (Research-use) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Japan Viral Vector Production (Research-use) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. India Viral Vector Production (Research-use) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. South Korea Viral Vector Production (Research-use) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Australia Viral Vector Production (Research-use) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Thailand Viral Vector Production (Research-use) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Viral Vector Production (Research-use) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Viral Vector Production (Research-use) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Argentina
7.5.3.1. Argentina Viral Vector Production (Research-use) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Viral Vector Production (Research-use) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. Saudi Arabia
7.6.2.1. Saudi Arabia Viral Vector Production (Research-use) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. UAE
7.6.3.1. UAE Viral Vector Production (Research-use) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. South Africa
7.6.4.1. South Africa Viral Vector Production (Research-use) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Kuwait Viral Vector Production (Research-use) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Merck KGaA
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. Lonza
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. Cobra Biologics Ltd
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. Thermo Fisher Scientific
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. Waisman Biomanufacturing
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. Genezen
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. YPOKESI
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. Advanced BioScience Laboratories, Inc. (ABL, Inc.)
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives
8.4.10. Novasep Holding S.A.S
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/ Strategic Initiatives
8.4.11. Orgenesis Biotech Israel Ltd (Formerly ATVIO Biotech Ltd)
8.4.11.1. Participant’s Overview
8.4.11.2. Financial Performance
8.4.11.3. Product Benchmarking
8.4.11.4. Recent Developments/ Strategic Initiatives
8.4.12. Vigene Biosciences, Inc.
8.4.12.1. Participant’s Overview
8.4.12.2. Financial Performance
8.4.12.3. Product Benchmarking
8.4.12.4. Recent Developments/ Strategic Initiatives

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.